Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes

Saved in:

Bibliographic Details
Published in:	Annals of oncology Vol. 30; no. 11; pp. 1682 - 1685
Main Authors:	Sveen, A., Cremolini, C., Dienstmann, R.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-11-2019
Subjects:	Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - pharmacology Bevacizumab - therapeutic use Biomarkers, Tumor - antagonists & inhibitors Biomarkers, Tumor - genetics Camptothecin - analogs & derivatives Camptothecin - pharmacology Camptothecin - therapeutic use Cetuximab - pharmacology Cetuximab - therapeutic use Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Consensus Female Fluorouracil - pharmacology Fluorouracil - therapeutic use Gene Expression Profiling - standards Gene Expression Regulation, Neoplastic Genetic Heterogeneity Humans Leucovorin - pharmacology Leucovorin - therapeutic use Male Middle Aged Models, Biological Molecular Targeted Therapy - methods Patient Selection Progression-Free Survival Randomized Controlled Trials as Topic Tumor Microenvironment - drug effects Tumor Microenvironment - genetics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdz412